CAS 219921-94-5 Repaglinide Related Compound A - Analytical Products / Alfa Chemistry

CAT	AP219921945
CAS	219921-94-5
Structure
Molecular Weight	435.56

Description	United States Pharmacopeia (USP) Reference Standard
Form	neat
Size	10MG

1

Absorption, Metabolism and Excretion of a Single Oral Dose of (14)C-repaglinide During Repaglinide Multiple Dosing

P N van Heiningen, V Hatorp, K Kramer Nielsen, K T Hansen, J J van Lier, N C De Merbel, B Oosterhuis, J H Jonkman

Eur J Clin Pharmacol. 1999 Sep;55(7):521-5.

PMID: 10501822

1

Repaglinide and Related Hypoglycemic Benzoic Acid Derivatives

W Grell, R Hurnaus, G Griss, R Sauter, E Rupprecht, M Mark, P Luger, H Nar, H Wittneben, P Müller

J Med Chem. 1998 Dec 17;41(26):5219-46.

PMID: 9857091

1

Repaglinide--a New Compound for the Treatment of Patients With Type 2 Diabetes

B H Wolffenbuttel

Neth J Med. 1999 Nov;55(5):229-34.

PMID: 10593133

1

Synthesis and Molecular Modeling of Novel Non-Sulfonylureas as Hypoglycemic Agents and Selective ALR2 Inhibitors

Manar G Salem, Yasmine M Abdel Aziz, Marwa Elewa, Hosam A Elshihawy, Mohamed M Said

Bioorg Med Chem. 2019 Aug 1;27(15):3383-3389.

PMID: 31221611

1

The Effects of Mitiglinide (KAD-1229), a New Anti-Diabetic Drug, on ATP-sensitive K+ Channels and Insulin Secretion: Comparison With the Sulfonylureas and Nateglinide

Y Sunaga, T Gonoi, T Shibasaki, K Ichikawa, H Kusama, H Yano, S Seino

Eur J Pharmacol. 2001 Nov 9;431(1):119-25.

PMID: 11716850

* Products or Services Interested: Repaglinide Related Compound A (219921-94-5)
* Your question
* Name
* Email
Verification Code